All companies › BLTE

BLTE · BELITE BIO, INC

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells8
Research cases0
Last filing2026-10-01

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-01 — Scholl Hendrik Peter · sold 200 @ $163.62 2026-10-01 — Scholl Hendrik Peter · sold 24 @ $164.64 2026-10-01 — Scholl Hendrik Peter · sold 120 @ $165.49 2026-10-01 — Scholl Hendrik Peter · sold 50 @ $166.44 2026-10-01 — Scholl Hendrik Peter · sold 78 @ $167.59 2026-10-01 — Scholl Hendrik Peter · sold 12 @ $168.21 2026-10-01 — Scholl Hendrik Peter · sold 14 @ $169.36 2026-10-01 — Scholl Hendrik Peter · sold 2 @ $170.02
2026-10-012026-10-01

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Scholl Hendrik Peter Chief Medical Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $BLTE is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 200.0, 'price': 163.625, 'value': 32725.0, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 24.0, 'price': 164.6408, 'value': 3951.38, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 120.0, 'price': 165.4935, 'value': 19859.22, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 50.0, 'price': 166.4368, 'value': 8321.84, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 78.0, 'price': 167.5876, 'value': 13071.83, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 12.0, 'price': 168.2117, 'value': 2018.54, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 14.0, 'price': 169.36, 'value': 2371.04, 'is_buy': False}, {'transaction_date': '2026-10-01', 'insider_name': 'Scholl Hendrik Peter', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 2.0, 'price': 170.02, 'value': 340.04, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for BLTE today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.